Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Kidney Stone Management Based on Stone Type

Stone-Specific Treatment Options

  • Potassium citrate is the first-line therapy to increase urinary pH to approximately 6.0, enhancing uric acid solubility, according to the American Urological Association 1
  • Potassium citrate should be offered to raise urinary pH to approximately 7.0 for patients with cystine stones, as recommended by the American Urological Association 1
  • Cystine-binding thiol drugs, such as alpha-mercaptopropionylglycine (tiopronin), should be offered to patients with cystine stones unresponsive to dietary modifications and urinary alkalinization, as suggested by the American Urological Association 1
  • Tiopronin is preferred over d-penicillamine due to better efficacy and fewer adverse events for patients with cystine stones, according to the American Urological Association 1
  • Urease inhibitors (acetohydroxamic acid or AHA) may be beneficial for patients with struvite stones, though side effects may limit use, as noted by the American Urological Association 1

Follow-up Care

  • A 24-hour urine specimen should be obtained within six months of initiating treatment to assess response to therapy, as recommended by the American Urological Association 1
  • Annual 24-hour urine collections are recommended for ongoing monitoring, with more frequent testing depending on stone activity, according to the American Urological Association 1
  • Periodic blood testing is necessary to monitor for adverse effects in patients on pharmacological therapy, such as hypokalemia with thiazides or hyperkalemia with potassium citrate, as suggested by the American Urological Association 1
  • Repeat stone analysis should be obtained when available, especially in patients not responding to treatment, as recommended by the American Urological Association 1

Common Pitfalls to Avoid

  • Prescribing allopurinol as first-line therapy for uric acid stones without addressing urinary pH is not recommended, as noted by the American Urological Association 1
  • Failure to monitor for medication side effects, such as hypokalemia with thiazides or hyperkalemia with potassium citrate, can be detrimental to patient care, according to the American Urological Association 1

Symptomatic Treatment for Kidney Stones

Hydration Therapy

  • Increased fluid intake to achieve urine output of at least 2.5 liters daily is critical for symptom management and stone prevention, as recommended by urology guidelines 2

Stone-Specific Treatments

  • For patients with calcium stones and low urinary citrate, potassium citrate therapy is indicated to increase urinary pH and inhibit stone formation, according to the American Urological Association 3, 4
  • Thiazide diuretics are recommended for patients with high urinary calcium and recurrent calcium stones, with dietary sodium restriction advised to maximize the hypocalciuric effect, as suggested by the American Urological Association 3, 5
  • For uric acid stones, potassium citrate is the first-line therapy to increase urinary pH to approximately 6.0, enhancing uric acid solubility, as recommended by the American Urological Association 6, 7
  • For cystine stones, increased fluid intake is particularly important, with a target of at least 4 liters per day to decrease urinary cystine concentration below 250 mg/L, as suggested by the American Urological Association 8, 5
  • Potassium citrate should be offered to raise urinary pH to approximately 7.0 for patients with cystine stones, as recommended by the American Urological Association 6, 7

Follow-up Care

  • A 24-hour urine specimen should be obtained within six months of initiating treatment to assess response to therapy, as recommended by the American Urological Association 7
  • Periodic blood testing is necessary to monitor for adverse effects in patients on pharmacological therapy, such as hypokalemia with thiazides or hyperkalemia with potassium citrate, as suggested by the American Urological Association 6

Common Pitfalls to Avoid

  • Inadequate fluid intake increases risk of stone recurrence, as noted by the American Urological Association 2
  • Using sodium citrate instead of potassium citrate may increase urine calcium excretion, as warned by the American Urological Association 4
  • Prescribing allopurinol as first-line therapy for uric acid stones without addressing urinary pH is not recommended, as cautioned by the American Urological Association 6, 7